Parkinson’s gene therapy restores responses to dopamine-boosting drug in mouse models
Parkinson’s gene therapy restores responses to dopamine-boosting drug in mouse [...]
Sangamo’s Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3
Sangamo’s Fabry gene therapy clears early clinical test, firing starting [...]
Bayer poaches Otsuka’s chief medical officer Koenen to head up its clinical operations
Bayer poaches Otsuka’s chief medical officer Koenen to head up [...]
After flops, Ironwood starts pipeline rebuild with liver disease deal
After flops, Ironwood starts pipeline rebuild with liver disease deal [...]
Cara chief hands keys to former LEO head Posner, months after first approval in its 17-year history
Cara chief hands keys to former LEO head Posner, months [...]
Turning CAR-T tech against solid tumors by targeting protein fragments in cancer cells
Turning CAR-T tech against solid tumors by targeting protein fragments [...]
Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure
Antios, months after series B, raises a further $75M to [...]
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers
Pfizer sells midphase inflammatory drugs to mystery startup, exiting race [...]
Legend’s status put on hold as FDA delays Janssen-partnered CAR-T decision
Legend’s status put on hold as FDA delays Janssen-partnered CAR-T [...]
Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech
Novartis makes protein degrader play, inking deal with new British [...]